(1S,2R)-1-(1-NAPHTHYL)-2-[(S)-1-AMINOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
Compound with spectra: 1 NMR
![(1S,2R)-1-(1-NAPHTHYL)-2-[(S)-1-AMINOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE](/api/compound/L96uhUw0leB.png?ph=true&h=300&w=458 "(1S,2R)-1-(1-NAPHTHYL)-2-[(S)-1-AMINOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE")
| SpectraBase Compound ID | L96uhUw0leB |
|---|---|
| InChI | InChI=1S/C21H28N2O.ClH/c1-4-19(22)18-14-21(18,20(24)23(5-2)6-3)17-13-9-11-15-10-7-8-12-16(15)17;/h7-13,18-19H,4-6,14,22H2,1-3H3;1H/t18-,19+,21+;/m0./s1 |
| InChIKey | KHGBXVBYKDGGJJ-TVCMNIOLSA-N |
| Mol Weight | 360.93 g/mol |
| Molecular Formula | C21H29ClN2O |
| Exact Mass | 360.196841 g/mol |
| Parent InChIKey | YDFPLZFFZJJCDJ-QKNQBKEWSA-N |
| Enantiomer InChIKey | KHGBXVBYKDGGJJ-LINKRLRISA-N |
| Copyright | Copyright © 2016-2025 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
(1S,2R)-1-(1-NAPHTHYL)-2-[(S)-1-HYDROXYPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
1-[3-Methyl-2-(1-naphthyl)-2-(piperidinoethyl)valeryl]pyrrolidine
(1S,4S,5R)-2-OXO-4-ETHYL-1-(1-NAPHTHYL)-3-OXABICYCLO-[3.1.0]-HEXANE
2-(1-naphthyl)-2-(o-tolylthio)pent-4-enoic acid methyl ester
Bicyclo[2.2.1]heptane-2-carboxylic acid, 6-nitro-3,5-olide-, methyl ester
YXMVGMRAJKBLJM-UHFFFAOYSA-N
N-(ALLYLOXYCARBONYL)-O-(2-ACETAMIDO-3,4,6-TRI-O-ACETYL-2-DEOXY-ALPHA-D-GALACTOPYRANOSYL)-L-SERINE-(METHOXYETHOXY)-ETHYLESTER
7,10-Diphentyl-8,9-diphenylfluoranthene
2-Amino-3-cyano-4-(1'-naphthyl)-1-phenyl-2-cyclopenten-1-ol
1,2,3,4-Tetrahydro-2-acetyl-1-[(methoxycarbonyl)methyl]-.beta.-carboline
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of derivatives of (1S,2R)-1-phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) modified at the 1-aromatic moiety as novel NMDA receptor antagonists: the aromatic group is essential for the activity | Bioorganic & Medicinal Chemistry | 2002 |